| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_07cd2c3f07e8d0a92b6f29e00a8e8d42 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-451
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-452
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4418 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4418
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-451
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-02 |
| filingDate |
2021-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8068a1aa43a42f07f600ff65a0f16b92
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9f8f68d731cc59907c19b46e2ac3cf0e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e09684e689da076fa8c36e3a20b37ea8 |
| publicationDate |
2022-08-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CL-2021003312-A1 |
| titleOfInvention |
Composition comprising pridopidine and an analog thereof for the treatment of huntington's disease and its symptoms. |
| abstract |
The present invention is directed to a method of treating a human patient affected by Huntington's disease and/or symptoms thereof, comprising the administration to the patient of a pharmaceutical composition comprising pridopidine or a pharmaceutically acceptable salt thereof and an analog thereof or a pharmaceutically acceptable salt thereof. |
| priorityDate |
2019-06-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |